Aperio Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $752K | Buy |
28,753
+3,876
| +16% | +$101K | ﹤0.01% | 1750 |
|
2020
Q3 | $433K | Sell |
24,877
-3,985
| -14% | -$69.4K | ﹤0.01% | 1890 |
|
2020
Q2 | $485K | Buy |
28,862
+5,098
| +21% | +$85.7K | ﹤0.01% | 1793 |
|
2020
Q1 | $283K | Buy |
23,764
+2,982
| +14% | +$35.5K | ﹤0.01% | 1938 |
|
2019
Q4 | $251K | Sell |
20,782
-1,984
| -9% | -$24K | ﹤0.01% | 2119 |
|
2019
Q3 | $322K | Buy |
22,766
+9,142
| +67% | +$129K | ﹤0.01% | 1985 |
|
2019
Q2 | $152K | Buy |
13,624
+2,460
| +22% | +$27.4K | ﹤0.01% | 2268 |
|
2019
Q1 | $131K | Sell |
11,164
-11,708
| -51% | -$137K | ﹤0.01% | 2222 |
|
2018
Q4 | $306K | Buy |
22,872
+8,351
| +58% | +$112K | ﹤0.01% | 1933 |
|
2018
Q3 | $203K | Sell |
14,521
-587
| -4% | -$8.21K | ﹤0.01% | 2183 |
|
2018
Q2 | $238K | Buy |
15,108
+109
| +0.7% | +$1.72K | ﹤0.01% | 2099 |
|
2018
Q1 | $246K | Buy |
+14,999
| New | +$246K | ﹤0.01% | 2043 |
|